Literature DB >> 11724799

Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils.

Shyra Gardai1, Ben B Whitlock, Cheryl Helgason, Dan Ambruso, Valerie Fadok, Donna Bratton, Peter M Henson.   

Abstract

Neutrophils undergo rapid spontaneous apoptosis. Multiple antiapoptotic stimuli can inhibit this process via activation of the Akt pathway. However, despite no such effect singly, combined anti- and proapoptotic stimuli inhibit Akt activity, leaving the cells susceptible to accelerated apoptosis. The blockade of Akt activation depended on reduced phosphoinositide 3,4,5-trisphosphate levels but not decreased phosphatidylinositol 3-kinase activity, thus implicating the involvement of an inositol phosphatase. Evidence for SHIP involvement was provided by SHIP localization to membrane receptors and subsequent activation along with the observed inability of SHIP -/- neutrophils to exhibit enhanced apoptosis with the stimulus combination. Activation of SHIP was found to depend on Lyn activation, and this, in turn, required NADPH oxidase. Neutrophils from chronic granulomatous disease patients and Lyn -/- mice no longer responded to the combined stimuli. Thus, we propose a role for oxidants and Lyn in SHIP regulation and suggest a novel mechanism for regulating neutrophil apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724799     DOI: 10.1074/jbc.M110005200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Macrophage polarization: the link between inflammation and related diseases.

Authors:  Samina Bashir; Yadhu Sharma; Asif Elahi; Farah Khan
Journal:  Inflamm Res       Date:  2016-01       Impact factor: 4.575

2.  Src family kinases play multiple roles in differentiation of trophoblasts from human term placenta.

Authors:  Georges Daoud; Eric Rassart; André Masse; Julie Lafond
Journal:  J Physiol       Date:  2006-01-12       Impact factor: 5.182

3.  Neutrophil spontaneous death is mediated by down-regulation of autocrine signaling through GPCR, PI3Kgamma, ROS, and actin.

Authors:  Yuanfu Xu; Fabien Loison; Hongbo R Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

4.  Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway.

Authors:  Gong-Ping Xu; Wei Zhao; Jin-Peng Zhuang; Jia-Ning Zu; Duan-Yang Wang; Fei Han; Zhi-Peng Zhang; Jing-Long Yan
Journal:  Tumour Biol       Date:  2014-11-05

5.  G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth.

Authors:  Quan-Sheng Zhu; Ling Xia; Gordon B Mills; Clifford A Lowell; Ivo P Touw; Seth J Corey
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

Review 6.  Role of neutrophils in innate immunity: a systems biology-level approach.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Nov-Dec

7.  Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.

Authors:  Ghazaleh Aram; James J Potter; Xiaopu Liu; Lan Wang; Michael S Torbenson; Esteban Mezey
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 8.  Multiple roles of Lyn kinase in myeloid cell signaling and function.

Authors:  Patrizia Scapini; Shalini Pereira; Hong Zhang; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Control of Bcl-2 expression by reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; Bruce Aronow; Sara Wojciechowski; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Mechanisms of neutrophil death in human immunodeficiency virus-infected patients: role of reactive oxygen species, caspases and map kinase pathways.

Authors:  S Salmen; H Montes; A Soyano; D Hernández; L Berrueta
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.